Yeong O. Baik
R&D Center
Seoul, Republic of Korea
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Year-Long Antibody Response to the EuCorVac-19 SARS-CoV-2 Vaccine in Healthy Filipinos.
Journal: Vaccines
Published: June 19, 2025
Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study.
Journal: The Lancet. Global health
Published: January 21, 2025
Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines.
Journal: Journal of medical virology
Published: March 10, 2024
One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 06, 2023
Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
Journal: The Lancet. Global health
Published: July 05, 2023
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial.
Journal: The Lancet regional health. Southeast Asia
Published: January 24, 2023
An open-label, comparative, single dose, clinical Phase Ⅰ study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults.
Journal: Vaccine
Published: January 25, 2021
Assignment of opsonic values to pneumococcal reference serum 007sp and a second pneumococcal OPA calibration serum panel (Ewha QC sera panel B) for 11 serotypes.
Journal: Vaccine
Published: September 15, 2020
Quality Improvement of Capsular Polysaccharide in Streptococcus pneumoniae by Purification Process Optimization.
Journal: Frontiers in bioengineering and biotechnology
Published: September 16, 2019
Development of a new 15-valent pneumococcal conjugate vaccine (PCV15) and evaluation of its immunogenicity.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: July 25, 2018
Last Updated: 09/26/2026